Get the Stockscreener App
21.65
0.93%
0.2074
Schrodinger Inc stock is traded at $21.65, with a volume of 332.73K.
It is up +0.93% in the last 24 hours and down -15.57% over the past month.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
See More
Previous Close:
$21.44
Open:
$21.31
24h Volume:
332.73K
Relative Volume:
0.29
Market Cap:
$1.39B
Revenue:
$193.35M
Net Income/Loss:
$-177.58M
P/E Ratio:
-8.8357
EPS:
-2.45
Net Cash Flow:
$-172.43M
1W Performance:
+1.12%
1M Performance:
-15.57%
6M Performance:
-4.12%
1Y Performance:
-0.64%
1-Day Range:
$20.90
$21.69
1-Week Range:
$20.90
$22.11
52-Week Range:
$16.60
$28.47
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
21.66 | 1.56B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
278.23 | 38.38B | 2.75B | 714.14M | 1.09B | 4.33 |
|
TEM
Tempus Ai Inc
|
54.95 | 10.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.09 | 8.67B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
52.04 | 9.63B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.64 | 6.61B | 906.14M | -52.62M | 89.62M | -0.3621 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
ProShare Advisors LLC Has $323,000 Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule - GuruFocus
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) To Newly Appointed Chief Commercial Officer - marketscreener.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Investors to Connect - ACCESS Newswire
Schrödinger Appoints Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing - citybiz
Schrödinger Expands Executive Leadership Team With Appointment Of Mannix Aklian As Chief Commercial Officer - marketscreener.com
Schrödinger Expands Executive Leadership Team with Appointment o - GuruFocus
Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing | SDGR Stock News - GuruFocus
Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $610,000 Stock Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Ameriprise Financial Inc. Has $2.67 Million Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc.SDGR - FinancialContent
RXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside? - Zacks Investment Research
BNP Paribas Financial Markets Makes New Investment in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger, Inc. (SDGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
When the Price of (SDGR) Talks, People Listen - news.stocktradersdaily.com
Leadership Transition at Schrödinger: Richie Jain Named CFO - MSN
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca's Pascal Soriot - Endpoints News
Schrödinger to Present at Jefferies Global Healthcare Conference - GuruFocus
Schrödinger to Present at Jefferies Global Healthcare Conference | SDGR Stock News - GuruFocus
Captrust Financial Advisors Takes $240,000 Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Layoff Tracker: Eikon Cuts Workforce by 15%, Citing ‘External Forces’ - BioSpace
Schrodinger Inc (SDGR) Shares Gap Down to $21.34 on May 20 - GuruFocus
Schrodinger appoints new CFO, Richie Jain By Investing.com - Investing.com Nigeria
Schrödinger: Regulatory Tailwinds Are Supportive Of Continued Strong Growth (Rating Upgrade) - Seeking Alpha
Schrödinger appoints new CFO as Porges steps down By Investing.com - Investing.com South Africa
Schrödinger appoints new CFO as Porges steps down - Investing.com Australia
SDGR Makes Notable Cross Below Critical Moving Average - Nasdaq
Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff - BioPharma Dive
SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff - Endpoints News
Schrödinger (SDGR) Announces CFO Transition and Reaffirms 2025 O - GuruFocus
Schrödinger Announces Chief Financial Officer Changes - marketscreener.com
Schrodinger names Richie Jain as new CFO - Investing.com
Schrodinger names Richie Jain as new CFO By Investing.com - Investing.com South Africa
Schrodinger appoints new CFO, Richie Jain - Investing.com
Schrödinger Announces CFO Appointment - marketscreener.com
Schrödinger Appoints Richie Jain as New CFO - TipRanks
Schrodinger says Richie Jain to succeed Geoffrey Porges as CFO - TipRanks
Schrödinger Announces CFO Appointment | SDGR Stock News - GuruFocus
Schrödinger Announces Workforce Reduction Amid Restructuring - TipRanks
Schrodinger Inc Says Schrödinger Restructures Operations To Reduce Workforce And CostsSEC Filing - marketscreener.com
Jane Street Group LLC Sells 10,012 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by Comerica Bank - Defense World
Schrödinger, Inc. (NASDAQ:SDGR) Shares Purchased by Northern Trust Corp - Defense World
The Manufacturers Life Insurance Company Sells 752 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of “Buy” by Analysts - Defense World
Schrodinger at BofA Healthcare: Strategic Growth and Challenges By Investing.com - Investing.com Nigeria
Schrodinger at BofA Healthcare: Strategic Growth and Challenges - Investing.com
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Schrodinger Inc Stock (SDGR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Akinsanya Karen | President of R&D, Therapeutics |
Apr 14 '25 |
Sale |
25.09 |
16,723 |
419,570 |
15,625 |
4.85%
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):